Cargando…
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies
Osteosarcomas are aggressive primary tumors of bone that are typically detected in locally advanced stages; however, which genetic mutations drive the cancer before its clinical detection remain unknown. To identify these events, we performed longitudinal genome‐sequencing analysis of 12 patients wi...
Autores principales: | Kovac, Michal, Ameline, Baptiste, Ribi, Sebastian, Kovacova, Monika, Cross, William, Barenboim, Maxim, Witt, Olaf, Bielack, Stefan, Krieg, Andreas, Hartmann, Wolfgang, Nathrath, Michaela, Baumhoer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361660/ https://www.ncbi.nlm.nih.gov/pubmed/33963544 http://dx.doi.org/10.1002/path.5699 |
Ejemplares similares
-
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
por: Ameline, Baptiste, et al.
Publicado: (2020) -
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
por: Barenboim, Maxim, et al.
Publicado: (2021) -
NTRK fusions in osteosarcoma are rare and non‐functional events
por: Ameline, Baptiste, et al.
Publicado: (2020) -
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
por: Kovac, Michal, et al.
Publicado: (2015) -
Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics
por: Engert, Florian, et al.
Publicado: (2016)